DOCSLIB.ORG

June 06.Indd

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
June 06.Indd NEWSLETTER Australasian Society for Immunology Incorporated PP 341403100035 ISSN 1442-8725 June 2006 Overview of the JCSMR Immunogenomics Laboratory 2006 Gerard Hoyne Overview they were able to reveal that the autoimmune but Dr Horikawa, a postodoctoral fellow in The Immunogenomics Laboratory at the regulator gene AIRE, which is expressed by the lab, has made the remarkable fi nding that John Curtin School of Medical Research in a subset of thymic epithelial cells, plays a the exact opposite is the case. The memory Canberra comprises four research groups critical role in establishing T cell tolerance B cell receptor is less active at inducing a working in concert to develop an integrated to self antigens in the thymus. In addition, subset of genes, and in this case less signal understanding of how our immune system is Adrian also identifi ed that defective signals means more antibody formation. controlled at the cellular and molecular level to cell death genes account for the inherited by circuits that are specifi ed in our genome resistance of T lymphocytes to clonal deletion Carola Vinuesa heads the Humoral sequence. Each of the groups focuses on in the thymus of NOD mice. Upon infection memory and Autoimmunity Group. a different element of a fundamental set with a virus or bacteria, B lymphocytes with Her group is investigating the cellular and of immune system decisions made at the the right antigen receptors to neutralize molecular events that regulate production level of individual immune system cells: infection are stimulated to switch the isotype and selection versus elimination of memory either to fi ght or to disarm. The process of of their receptor from IgM to IgG, and at the B cells which is of critical importance to deciding which immune cells should fi ght same time secretion of antibodies by these understand how best to harness immune and which should disarm is key to our ability switched cells is dramatically increased. responses against infection, and to mitigate to resist infection and parasitism. Mistakes A previous PhD student, Dr Steve Martin, against autoimmunity. One approach in this process result in incurable infections, discovered that the switched receptor – and utilised by Vinuesa’s group is to survey autoimmune diseases, allergy, lymphoma, indeed a small tail segment uniquely found the mammalian genome by ENU mouse and leukaemia. Moreover, drugs and other in switched receptors – explains the dramatic mutagenesis to identify single point ways to alter fi ght or disarm decisions are elevation of antibody secretion that serves mutations that predispose to systemic sorely needed to improve the success of organ as the cardinal measure of immunological transplantation and treatment of autoimmune memory. It was thought that the IgG tail cont. p4 diseases and metastatic cancer. would enhance antibody production by enhancing a signal within B lymphocytes, Contents For a long time it was not possible to see how memory and effector cells are JCSMR Immunogenetics Laboratory 1 made, nor how self-reactive lymphocytes disarm themselves. The Immunogenomics Editorial 3 Laboratory headed by Chris Goodnow has Day of Immunology 2006 3 pioneered ways to visualize these processes Treasurer’s Report on Audit 3 in genetically modifi ed transgenic mice. By studying cells from the transgenic mice, SIG Mucosal Immunology Update 5 we have discovered that each immune cell Councillors' News 6 must run through a complex series of fi ght 2004–2005 Audit Report 8 or disarm checkpoints before it can be fully ASI Student Page 12 launched into an immune response. In some ways, the process resembles the sequence of 2006 ASI Conference 13 fi ght/disarm decisions in a military missile Comments from ASI Members 16 launch, which serve a similar purpose of An Immunological Saga 17 preventing friendly fi re and optimising targeting against invaders. Together with Upcoming Lectures & Conferences 20 Adrian Liston a former PhD student in the lab Chris Goodnow ASI Inc. Newsletter June 2006 ASI Inc. COUNCIL President Vice President Dr Philip Hodgkin Professor Alan Baxter Non-Voting Councillors: Walter & Eliza Hall Institute CGC, James Cook University 1G Royal Parade Townsville Qld 4811 Newsletter Editor Parkville Vic 3050 Ph: 07 4781 6265 Fax: 07 4781 6078 Dr Miles Davenport Ph: 02 9385 2762 Fax: 02 9385 1389 Ph: 03 9345 2609 Fax: 03 9347 0852 Email: [email protected] Email: [email protected] Email: [email protected] Journal Editor Professor Chris Parish Honorary Secretary Honorary Treasurer Ph: 02 6125 2604 Fax: 02 6125 2595 Dr Jose Villadangos Dr Norbert Kienzle Email: [email protected] Walter & Eliza Hall Institute Queensland Institute of Medical Research 1G Royal Parade 300 Herston Road Visiting Speakers Co-ordinator Parkville Vic 3050 Brisbane Qld 4006 A/Prof J. Alejandro Lopez Ph: 03 9345 2532 Fax: 03 9347 0852 Ph: 07 3362 0379 Fax: 07 3362 0105 Queensland Institute of Medical Research Email: [email protected] Email: [email protected] CBCRC/I, Post Offi ce Royal Brisbane Hospital Qld 4029 Ph: 07 3845 3794 Fax: 07 3845 3510 State Councillors Email: Email: [email protected] New South Wales Victoria & Tasmania Council Member of IUIS Dr Bernadette Saunders Dr Phillip Darcy Professor Chris Parish Ph: 02 9565 6114 Fax: 02 9565 6101 Ph: 03 9656 3769 Fax: 03 9656 1411 Ph: 02 6125 2604 Fax: 02 6125 2595 Email: [email protected] Email: [email protected] Email: [email protected] Honorary Archivist & Webmaster: Queensland South Australia & Northern Territory Dr Judith Greer Dr Christopher Schmidt Dr Claudine Bonder Ph: 07 3365 5133 Fax: 07 3365 5462 Ph: 07 3362 0313 Fax: 07 3362 3510 Ph: 08 8222 3852 Fax: 08 8232 4092 Email: [email protected] Email: [email protected] Email: [email protected] Administrative Correspondence Western Australia Australian Capital Territory Ms Judi Anderson Dr Chris Andoniou Dr Guna Karupiah ASI Inc. Secretariat Ph: 08 9381 0799 Fax: 08 9381 0700 Ph: 02 6125 4562 Fax: 02 6125 2595 PO Box 7108 Email: [email protected] Email: [email protected] Upper Ferntree Gully Vic 3156 Ph: 03 9756 0128 Fax: 03 9753 6372 New Zealand Email: [email protected] Prof John Fraser Ph: +64 9 373 7599 ext 86036 Fax: +64 9 373 8774 Email: [email protected] FIMSA Councillor Contact for Tasmania Professor Nicholas King Dr Greg Woods Ph: 02 9351 4553 Fax: 02 9351 3429 Tel: 03 6226 4830 Fax: 03 6226 4833 Email: [email protected] Email: [email protected] Website The ASI web site (www.immunology.org.au) has been fully remodelled and updated. New services include: ¾ Downloadable forms for ASI awards, ¾ Positions vacant pages, ¾ Jobs wanted pages, ¾ Upcoming conferences listings, as well as a plethora of links to sites of immunological interest at home and abroad. If you‛d like your lab home pages linked to the site, would like to advertise a job or conference, or have a favourite immunology- related site that doesn‛t currently appear on the ASI site, please email Judy Greer at j.greer@medicine. uq.edu.au Email bulletin board To subscribe to the ASI bulletin board, send an email to [email protected] with the message: subscribe anz-imm. 2 ASI Inc. Newsletter June 2006 EDITORIAL The Day of Treasurer’s report Immunology – on the Financial This quarter’s newsletter brings exciting details of the upcoming annual conference April 29, 2006 Audit for ASI for in Auckland in December. A list of speakers For the second consecutive year the European is included on pages 13-15, and conference Federation of Immunological Societies 2004/2005 details can be found at the website below. (EFIS) has organised the Day of Immunology (DoI) on April 29. This year, the emphasis ASI passed its inaugural fi nancial audit A new addition to the newsletter is the was on delivering information about the with fl ying colours. As stated previously annual audit of ASI’s fi nances (p8-11). The discipline of Immunology to school kids. to the membership, record growth Council thought it important to share this with Most of the activities took place in Germany (note, not net) income and Victorian members so we can all know our membership (Berlin, Hannover, Munich, Erlangen) and Government laws made it necessary that funds are being managed well. If reading Denmark and included conferences and ASI underwent an independent audit for this is not enough of a challenge, we also meetings of general interest dealing with the fi nancial year from 1 November 2004 have our fi rst “immunology crossword” by subjects such as antibody-therapy, avian to 31 October 2005. Margaret Crossley our student representative Amanda Taylor infl uenza and multiple sclerosis. from WHK Day Neilson in Melbourne (p12) to test your mental agility. undertook the audit and her fi ndings The main project was the launching of are to be found on pages 8–11 of this Finally, some refl ections by Tony Basten on the prize for “Partners in Immunology newsletter . pages 17-20. Tony retired as director of the and Education” (PIE) which will reward Centenary Institute earlier this year and his proposals fostering the interactions between As stated in the summary of income article is a very humorous and interesting research institutes and schools that facilitate and expenditure, ASI has a total of recount of his adventures during a life in the understanding of Immunology by school $333,743 in accumulated funds including immunology. children. The prize of €1500 will be awarded a surplus of $50,520. These fi gures are during the coming European Immunology slightly higher as the ones stated in Miles Davenport Congress in Paris (Sept.
Load more

Recommended publications
  • The John Curtin School of Medical Research Annual Review 2012
    THE JOHN CURTIN SCHOOL OF MEDICAL RESEARCH ANNUAL REVIEW 2012 ANU College of Medicine, Biology & Environment CONTENTS Annual Review 2012 From the Director 3 The John Curtin School of Medical Organisation Chart 4 Research Committees 5 COMMUNITY 7 Official Opening of Stage 3 8 Launch of The John Curtin Medical Research Foundation 9 Professor Gordon Ada 10 Open Day 11 Community Activities 12 RESEARCH IN REVIEW 2012 15 Eccles Institute of Neuroscience 16 Department of Genome Biology 29 Department of Immunology 36 Department of Pathogens and Immunity 45 Department of Molecular Bioscience 47 Department of Translational Medicine 56 Australian Phenomics Facility 60 Biomolecular Resource Facility/Genome Discovery Unit 61 STAFF AND STUDENT ACHIEVEMENTS 63 VISITORS AND COLLABORATIONS 69 STAFF AND STUDENTS 85 Department of Genome Biology 86 Department of Immunology 87 Eccles Institute of Neuroscience 88 Department of Pathogens and Immunity 90 Department of Molecular Bioscience 90 Department of Translational Medicine 92 APF and Animal Services 92 School Services 94 School Administration 95 Students 96 PUBLICATIONS, PRESENTATIONS AND COMMUNITY OUTREACH 99 SUPPORT 129 Grants 130 Financial Overview 134 Donors 135 Sponsors 136 Annual Review 2012 1 2 The John Curtin School of Medical Research FROM THE DIRECTOR Zinkernagel. He will be sadly missed by his many friends and colleagues at the School, who have established the annual Gordon Ada New Investigator Award in his memory. In 2012, we finally completed the long and very necessary redevelopment project that resulted in the new John Curtin School of Medical Research building on the ANU campus. All our staff and students are once again under one roof, carrying out their research in state of the art laboratories and facilities.
    [Show full text]
  • Understanding Genomics
    Predict Diagnose Treat Understanding genomics A comprehensive guide brought to you by Garvan. Contents What is genomics? 4 A short history of DNA 5 Genomics information for a lifetime 7 Conversations about genomics 11 How does genome sequencing work? 12 Can I have my genome sequenced? 13 Genomics research at Garvan 14 Garvan’s genomics research programs 18 Genomics research centres 20 Useful terms 22 Predict Diagnose Treat 2 3 Professor Chris Goodnow FAA FRS Executive Director, Garvan Institute of Medical Research The Bill and Patricia Ritchie Foundation Chair Dear Friend, I’m Professor Chris Goodnow, Executive Director of the Garvan Institute of Medical Research in Sydney. I wanted to introduce myself and thank you for your interest in understanding genomics. Genomics is the study of genes and other information encoded in an individual’s genome—the complete set of instructions in their DNA. Each person has different DNA, unique just to you. Every disease has a genetic component. Through genomics research, we can further understand what our genetic information – and our gene or genetic variations – mean for our health. Garvan scientists use genomics research to understand more about disease and determine how to best diagnose, treat and prevent it. I hope you find this brochure informative and useful and consider joining our family, pioneering the future of medical research. Yours sincerely, Chris We see a future where an individual’s DNA is used to better predict, diagnose and treat disease. It’s within reach. 2 3 What is genomics? Genomics is the study of your genome – all the information encoded in your DNA.
    [Show full text]
  • Annual Report (March 2010-February 2011)
    EMBL Australia Annual Report [March 2010 – February 2011] 2 EMBL AUSTRALIA ANNUAL REPORT 2009–10 Contents Chairman’s report 2 Scientific Head’s report 3 About EMBL Australia 4 The European Molecular Biology Laboratory 4 2010 Highlights 5 2011 Outlook 6 Key activities 7 Launch by Minister Carr 7 Appointment of Scientific Head 8 EBI Mirror Facility and the National Bioinformatics Network 8 EBI Mirror at The University of Queensland 8 EMBL Australia Bioinformatics Network 9 International PhD Program 9 Partner Laboratory Network 9 Appointment of Edwina McGlinn 10 Appointment of Nicolas Platcha 11 Faculty Development Program 11 Sponsorship of BioInfoSummer 11 Governance 12 EMBL Australia participant expansion 12 Council 12 Appointment of new members 12 Council Members 12 Meetings 12 Planning and Finance Committee 13 Members 13 Meetings 13 Bioinformatics Committee 13 Members 13 Meetings 13 Staff 14 Australian visitors to EMBL 2010 15 Visitors to EMBL Australia 15 Financial report 16 Documents and Media releases 18 Funding & Stakeholders 20 Participants 20 Funding and in-kind support 20 Contact details inside back cover 1 Chairman’s report 2010 was a seminal year in the EMBL Australia initiative. Our official launch by Minister Carr in March coincided with the announcement of several key developments. These developments included the appointments of our Scientific Head and first Partner Laboratory Group Leaders, along with the announcement of a second node and associated national network for bioinformaticians. EMBL Australia’s participation is set to expand, with invitations accepted by the remaining Go8 universities to join EMBL Australia. This will extend direct involvement to a wider group of research institutions and expand the potential reach of EMBL Australia programs.
    [Show full text]
  • THE JOHN CURTIN SCHOOL of MEDICAL RESEARCH Annual Review 2013
    THE JOHN CURTIN SCHOOL OF MEDICAL RESEARCH Annual Review 2013 ANU College of Medicine, Biology & Environment CONTENTS Annual Review 2013 The John Curtin School of Medical Research From the Director 3 Staff and student lists 87 Department of Genome Biology 88 Organisation Chart 4 Department of Immunology 90 Committees 5 Eccles Institute of Neuroscience 92 Department of Molecular Bioscience 94 Community 7 Department of Translational Medicine 96 Department of Pathogens and Immunity 96 Centenary of Canberra 2013 Australian Phenomics Facility 97 14th Frank and Bobbie Fenner Conference 8 School Administration 98 The John Curtin Medical Research Foundation Dinner 9 School Services 98 David Curtis Reading Room 10 The ACRF Biomolecular Resource Facility Open Day 2013 11 and Genome Discovery Unit 99 Community Activities 12 Students 100 Research in Review 2013 15 Publications, presentations and Eccles Institute of Neuroscience 16 community outreach 103 Department of Genome Biology 30 Publications 104 Department of Immunology 38 Staff Presentations 110 Department of Pathogens and Immunity 48 Student Presentations 117 Department of Molecular Bioscience 52 Community Outreach 121 Department of Translational Medicine 58 Australian Phenomics Facility 60 Support to JCSMR 131 The Imaging and Cytometry Facility 62 Grants 132 The ACRF Biomolecular Resource Facility Financial Overview 136 and Genome Discovery Unit 63 Donors 137 Staff and student achievements 65 Sponsors 138 Graduates 66 Prizes and Awards 67 Visitors and collaborations 71 Visitors 72 Collaborations 74 Annual Review 2013 1 2 The John Curtin School of Medical Research FROM THE DIRECTOR Following the opening of Stage 3 of our new building in 2012, JCSMR staff and students have enjoyed the opportunities provided by the new spaces, including the laboratories, and meeting rooms such as the Science Forum.
    [Show full text]
  • 2019 Annual Report
    Annual Report 2019 Garvan Institute of Medical Research Annual Report 2019 2019 Strength through collaboration Our vision Our values We see a future where everyone lives a longer, healthier life. Excellence Our mission Innovation We will harness all the information encoded in the genome Collaboration to better diagnose, predict, treat and prevent diseases that have the deepest impact on society. Community Integrity Respect Who we are, what we do The Garvan Institute of Medical Research brings together world-leading clinicians and basic and translational researchers. We are patient focused. Our researchers break down barriers between traditional scientific disciplines to find solutions to disease. Founded in 1963, Garvan’s researchers have made significant advances in genome, epigenome, protein and cell analysis technology. We have revealed causes and developed treatments for diseases including diabetes, osteoporosis, cancer, immune deficiency and autoimmunity. Today, Garvan’s mission builds on those advances, harnessing all the information encoded in our genome, from DNA to complex organ systems, to better diagnose, treat, predict and prevent disease. Garvan’s research has global impact. World-leading people pioneer discoveries across four intersecting research themes. We lead the field in medical genomics, epigenetics, and cellular genomics; cancer; diseases of immunity and inflammation; and diseases of ageing affecting bone, brain and metabolism. Our goal is to translate discovery into meaningful health benefits for those living with disease and their family. Patients, clinical trial cohorts and population cohorts are at the centre of Garvan’s research. We are focused on addressing the unmet needs of those living with disease – where better understanding, new treatments and more effective diagnosis can have the biggest impact.
    [Show full text]
  • 2018 Annual Report 2018 Our Year of Big Thinking, Collaboration and Discovery
    2018 Annual Report 2018 Our year of big thinking, collaboration and discovery. Our vision Our values We see a future where everyone lives a longer, Excellence healthier life. Innovation Our mission Collaboration We will harness all the information encoded in Community the genome to make pioneering discoveries that Integrity predict, treat and prevent diseases that have the deepest impact on society. Respect 2018 Garvan Annual Report Our values Who we are, what we do Aspirations Excellence Garvan is leading the nation in using genomic analysis • To become the most advanced institute in the to accelerate discovery and enable personalised, region in the adoption, application and integration Innovation precision medicine. of next-generation genomic and computational approaches and technologies in investigative and Collaboration Our researchers pioneer studies into some of the most translational research. difficult to solve and widespread diseases affecting the Community community today. Garvan is focused on understanding • To advance knowledge in our key areas of critical the molecular and cellular processes in health and mass that will lead to better understanding, reduced Integrity disease, putting people and patients at the centre of incidence and improved treatments for cancer, leading-edge local and global research expertise and immune deficiency, inflammatory and autoimmune Respect networks as the basis for developing future preventions diseases including diabetes, osteoporosis, and and treatments. diseases of ageing affecting the brain and other organs. For 56 years, Garvan scientists have been achieving significant breakthroughs in the understanding and • To attract, develop and support exceptionally talented treatment of diseases. researchers with leading-edge programs addressing key conceptual and practical questions in human biology, and the translation of new knowledge and technologies into clinical applications.
    [Show full text]
  • 2017 Annual Report GARVAN INSTITUTE of MEDICAL RESEARCH MISSION and VISION
    BREAKTHROUGH MEDICAL RESEARCH 2017 Annual Report GARVAN INSTITUTE OF MEDICAL RESEARCH MISSION AND VISION To make significant contributions to medical research that will change the directions of science and medicine and have major impacts on human Respect Passion health. Garvan’s ultimate goal is prevention and treatment of major diseases. Collaboration Values Excellence Innovation Integrity Who we are, Aspirations • To attract, develop and support exceptionally talented what we do • To become the most researchers with leading‑edge advanced institute in the programs addressing key Garvan is leading the nation region in the adoption, conceptual and practical in using genomic analysis to application and integration of questions in human biology, accelerate discovery and enable next‑generation genomic and and the translation of new personalised, precision medicine. computational approaches and knowledge and technologies technologies in investigative into clinical applications. Our researchers pioneer and translational research. studies into some of the most • To embrace and uphold a culture widespread diseases affecting • To advance knowledge in our of collegiality, collaboration, the community today. Garvan is key areas of focus that will inclusivity, consideration, focused on understanding the lead to better understanding, safety, transparency, and role of molecular and cellular reduced incidence and high ethical standards. processes in health and disease improved treatments for cancer, as the basis for developing future osteoporosis, diabetes, obesity, • To engage stakeholders preventions and treatments. and immunological, skeletal and and the community with our neurological diseases, and achievements and research For 55 years, Garvan to influence health policy. vision so that we attract the scientists have been achieving significant government and significant breakthroughs donor support needed in the understanding and to empower our treatment of diseases.
    [Show full text]
  • Breakthrough Magazine June E Corkery Angele Labossiere Eric Swarbrick Please Visit Garvan.Org.Au/Previous-Seminars
    August 2018 | Issue 39 breakthrough Trust your gut How your bacteria could save you from type 2 diabetes Meet Professor Chris Goodnow, Garvan’s new Executive Director Living an extraordinary life with rare cancer Welcome NEW RESEARCH from our It’s DNA, but not as we know it Executive In a world first, our researchers Associate Professor Daniel Christ, Associate Professor Marcel Dinger and Director Dr Mahdi Zeraati found a new DNA structure – a twisted ‘knot’ they call the i-motif – inside cells. The iconic ‘double helix’ shape of DNA has captured the public imagination since 1953; however, it’s now known that DNA can exist Dear Garvan family, in a few other shapes – in a test tube, at least. Until now, the i-motif had never before been directly seen inside I’m so pleased to be able to introduce your August issue of living cells. In fact, scientists had debated whether i-motif Breakthrough and to have this opportunity to thank you for ‘knots’ would exist at all inside living things – a mystery your support. Many of you know me from my three years as that is now solved. Garvan researchers suspect i-motif Deputy Director here at Garvan. I’m honoured to have been DNA plays an important role in switching genes on or off. appointed as the Institute’s fourth Executive Director and build on the legacy of the Institute’s pre-eminent leaders. See the i-motif DNA at garvan.org.au/new-dna. I’d like to briefly share with you my vision for the future of Garvan, in which we continue our progress towards precision medicine based on each person’s DNA.
    [Show full text]
  • Garvan Institute's Guide to Positive Ageing
    Positive ageing A comprehensive guide brought to you by Garvan. PB 1 Contents Introduction 1 What is healthy ageing? 2 What happens to your body as it ages 4 Diseases of ageing 12 Healthy ageing – what you can do 14 Garvan & diseases of ageing 16 Medical Genome Reference Bank 24 We see a future where everyone lives longer, healthier lives. 1 Professor Chris Goodnow FAA FRS Executive Director, Garvan Institute of Medical Research The Bill and Patricia Ritchie Foundation Chair Dear Friend, I’m Professor Chris Goodnow, Executive Director of the Garvan Institute of Medical Research, one of Australia’s premier research facilities. I wanted to introduce myself and thank you for requesting our brochure on positive ageing. As precision medicine and advances in healthcare enable people to live longer than ever before, the ability to live not only long, but healthy lives is becoming increasingly critical. We know that ageing healthily relies on a complex mix of genetic, environmental and social factors. However, there are actions that can be taken now to help ensure that older adults maintain their physical and emotional health, whatever their age or circumstances. We are focused on addressing the unmet needs of those living with disease – where better understanding, new treatments and more effective diagnosis can have the biggest impact in order to create a future where people can live longer, healthier lives. Yours sincerely, Chris We see a future where an individual’s DNA is used to better predict, diagnose and treat disease. It’s within reach. 1 What is healthy ageing? With age comes the increased risk of disease or infirmity.
    [Show full text]
  • Mutations, Tolerance Checkpoints, Autoimmunity and Lymphoid Cancer
    Mutations, tolerance checkpoints, autoimmunity and lymphoid cancer PROFESSOR CHRISTOPHER C GOODNOW FAA FRS Executive Director, Garvan Institute of Medical Research ABSTRACT Distinguishing self from microbe is a fundamental problem for adaptive and innate immune receptors, balancing between the need for specificity and polyreactivity. Self-reactive antibodies are displayed as surface receptors on many B lymphocytes, and continuously signal responses within the B cell upon binding self antigens. A series of checkpoints and feedback mechanisms normally prevent these signals from activating relentless B cell proliferation and the potential for autoimmunity or lymphoma/leukemia. Here I will describe recent experiments analysinghow cells bypass these checkpoints by acquiring somatic mutations in the immunoglobulin V-regions and in lymphoma driver genes. 31 Thursday 1 August, 2019 ABOUT THE PRESENTER 1:00 - 2:00pm Professor Chris Goodnow FAA FRS is Executive Director of the Garvan Institute of Medical Research, holds The Bill and Patricia Ritchie Foundation H1 Lecture Theatre, Chair as Head of the Immunogenomics Laboratory at Garvan, and is Professor and Director of the Cellular Genomics Futures Institute at UNSW 20 Chancellors Walk Sydney. Chris trained in veterinary medicine and surgery, immunochemistry, Clayton campus and immunology at the University of Sydney and in DNA technology at Stanford University. Chris is internationally recognised for discovering and establishing the concept of sequential checkpoints for the immune system to tolerate “self” while fighting off “foreign” infections, laying the scientific foundation for the recent success of checkpoint inhibitor drugs to activate immune destruction of “self” cancer cells. He pioneered the use of genome sequencing to reveal how the body’s phenotype results from its’ genotype – “phenomics”.
    [Show full text]
  • Let Them Eat Cake Celebrating the Day of Immunology Throughout Australasia
    2016 ASI JUNE NEWSLETTER Let them eat cake Celebrating the Day of Immunology throughout Australasia Also in this issue Contact Us Australasian Society for Immunology Inc. • Knowledge Nation - Misty • Jaw-dropping beauty from PO Box 7108, Upper Ferntree Gully VIC 3156 Jenkins and DNA Nation Snapshots of the Immune Australia • Getting the news across - Peter system exhibition in Melbourne P: +61 3 9756 0128 Doherty interviewed by Erika • More delcious pictures of cake! E: [email protected] Duan International Congress of Immunology 2016 IMMUNOTHERAPY: HARNESSING THE POWER OF THE IMMUNE SYSTEM www.ici2016.org ICI 2016 Hosted by Invitation from the ICI 2016 President ICI 2016 promises to be an unforgettable event that will bring together delegates from all over the world. We anticipate over 3000 participants, including international leaders at the forefront of the discipline that will present the most recent advances in basic immunology and clinical treatments. This is an opportunity to be part of a major international immunology meeting in Australia as the last ICI was held in Sydney back in 1977. The Congress will provide a key networking and educational interface for colleagues from industry, university, health providers and independent research organisations to come together. Jose Villadangos President, International Congress of Immunology 2016 Peter Doherty Institute and Bio21 Institute, The University of Melbourne AXM0440 ICI 2016 Double Page Spread update.indd 2 13/05/2016 11:13 AM SOME OF THE CONFIRMED SPEAKERS Shizuo
    [Show full text]
  • N E W S L E T T
    NEWSLETTER Australasian Society for Immunology Incorporated PP 341403100035 ISSN 1442-8725 March 2011 Remembering Frank Fenner Phil Hodgkin Before the start of the scientifi c program But Fenner is perhaps most famous for at the 2010 ASI meeting I was asked to chairing the WHO global commission deliver a short tribute to our long time for the certification of smallpox colleague and great friend Frank Fenner eradication. In this capacity Frank had who passed away the week before the the honour of announcing to the world meeting at the age of 95. In paying such that smallpox had been eradicated in a tribute it was diffi cult to know where 1980. Surely one of the greatest ever to start – his lifetime of contribution to public health achievements. Afterwards science was simply extraordinary. Fenner teamed up with Donald Henderson to write a comprehensive Frank Fenner published his first history of the disease – from its murky scientifi c paper in 1934 at age 20, beginnings in history to its end brought an anthropological study of South about by vaccination. Australian aboriginal communities, and continued to publish well into his In addition to his stellar scientifi c 80s – an incredible 70 year publication work, Fenner was a tireless leader and span. scientifi c administrator. In the late cont. p4 Fenner worked as an army doctor during Professor Frank Fenner AC CMG MBE 2007 the Second World War, serving fi rst in by Jude Rae. oil on canvas. Collection: National Portrait Palestine and later in New Guinea. In Gallery, Canberra. Commissioned with funds provided by Contents New Guinea he developed strategies for Mr Anthony Adair and Ms Karen MacLeod protecting Australian troops from malaria Remembering Frank Fenner 1 of the Nobel prize to Burnet and Medawar and achieved such great success that his work Editorial 3 in 1960.
    [Show full text]